These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25717230)

  • 1. Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients.
    Wu W; Chen M; Yan K; Dai Y; Yin S; Yang W; Fan Z
    Chin J Cancer Res; 2015 Feb; 27(1):83-9. PubMed ID: 25717230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound.
    Jang HJ; Kim TK; Wilson SR
    Eur J Radiol; 2009 Dec; 72(3):418-24. PubMed ID: 18834687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
    Duan Y; Xie X; Li Q; Mercaldo N; Samir AE; Kuang M; Lin M
    Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: Comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography.
    Dai Y; Chen MH; Fan ZH; Yan K; Yin SS; Zhang XP
    Hepatol Res; 2008 Mar; 38(3):281-90. PubMed ID: 17908168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.
    Chen S; Qiu YJ; Zhang Q; Lu XY; Huang YL; Dong Y; Wang WP
    Ultrasound Med Biol; 2024 Jan; 50(1):39-46. PubMed ID: 37778901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Early Hepatocellular Carcinoma and High-Grade Dysplastic Nodules on Contrast-Enhanced Ultrasound: Correlation With Histopathologic Findings.
    Fan PL; Xia HS; Ding H; Dong Y; Chen LL; Wang WP
    J Ultrasound Med; 2020 Sep; 39(9):1799-1808. PubMed ID: 32378794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
    Numata K; Fukuda H; Nihonmatsu H; Kondo M; Nozaki A; Chuma M; Morimoto M; Oshima T; Okada M; Murakami T; Takebayashi S; Maeda S; Inayama Y; Nakano M; Tanaka K
    Abdom Imaging; 2015 Oct; 40(7):2372-83. PubMed ID: 26099473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced Ultrasound.
    Chen S; Qiu YJ; Zuo D; Shi SN; Wang WP; Dong Y
    Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36291962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study.
    de Sio I; Iadevaia MD; Vitale LM; Niosi M; Del Prete A; de Sio C; Romano L; Funaro A; Meucci R; Federico A; Loguercio C; Romano M
    United European Gastroenterol J; 2014 Aug; 2(4):279-87. PubMed ID: 25083285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Perfusion Features of Recurrent Hepatocellular Carcinoma After Radiofrequency Ablation Using Contrast-Enhanced Ultrasound and Pathological Stemness Evaluation: Compared to Initial Tumors.
    Wu JY; Bai XM; Wang H; Xu Q; Wang S; Wu W; Yan K; Yang W
    Front Oncol; 2020; 10():1464. PubMed ID: 32983980
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.
    Wong GL; Xu HX; Xie XY
    World J Radiol; 2009 Dec; 1(1):25-36. PubMed ID: 21160718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis.
    Kim TK; Jang HJ
    World J Gastroenterol; 2014 Apr; 20(13):3590-6. PubMed ID: 24707142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique].
    Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.
    Kim TK; Lee KH; Khalili K; Jang HJ
    Abdom Imaging; 2011 Jun; 36(3):244-63. PubMed ID: 21253723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound.
    Giorgio A; Calisti G; di Sarno A; Farella N; de Stefano G; Scognamiglio U; Giorgio V
    Anticancer Res; 2011 Nov; 31(11):3977-82. PubMed ID: 22110230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study.
    Dong Y; Wang WP; Lee WJ; Meloni MF; Clevert DA; Chammas MC; Tannapfel A; Forgione A; Piscaglia F; Dietrich CF
    Ultrasound Med Biol; 2022 Sep; 48(9):1797-1805. PubMed ID: 35710501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US.
    Sugimori K; Numata K; Okada M; Nihonmatsu H; Takebayashi S; Maeda S; Nakano M; Tanaka K
    J Med Ultrason (2001); 2017 Jan; 44(1):89-100. PubMed ID: 27771842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.